Global Neurology Academy
The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
31-45 of 57
From Evidence to Everyday Practice: Using Real-World Data to Refine TD Algorithms
MinuteCE®From Evidence to Everyday Practice: Using Real-World Data to Refine TD Algorithms
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
MinuteCE®Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
Tracy Hicks, DNP, MBA
Melissa Moody, MD
VMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
MinuteCE®VMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Not All VMAT2s Are the Same: Understanding the PK/PD Differences
MinuteCE®Not All VMAT2s Are the Same: Understanding the PK/PD Differences
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Tracy Hicks, DNP, MBA
Melissa Moody, MD
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
- advertisement
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CEOptimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CEAre All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
CME/CEMechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
CME/CEAdvances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Christoph U. Correll, MD
- advertisement
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Vera Bril, MD
Nicholas J. Silvestri, MD
Hans Katzberg, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
MinuteCE®Managing Side Effects in FcRn Therapy: Best Practices for gMG
Vera Bril, MD
Nicholas J. Silvestri, MD
